Safety and Efficacy Study of TNX-650 to Treat Refractory Hodgkin's Lymphoma

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2006
The purpose of this study is to determine the safety and effectiveness of TNX-650 for Injection when administered to patients with refractory Hodgkin\'s lymphoma.
Epistemonikos ID: c1c75663513ea5a9101d96720f0f8c4b2f156b8d
First added on: May 04, 2024